Moderna Gains Almost 8% With Nasdaq Recovery; Cancer Vaccine Pipeline Still a Key Focus
Moderna Inc. bounced back on Thursday, finishing the session at $49.64 for a gain of $3.65, or 7.94%. Shares started the day at $46.43 and moved between $46.30 and $49.94. Wednesday saw the stock drop 3.65% to close at $45.99, Investing.com data showed. The stock slipped to $49.16 in early after-hours trade near 5 p.m. ET. The rally matched a broader move up in U.S. stocks, with no confirmed news out of the company during Thursday’s session. Reuters said the S&P 500 jumped 1.75%, the Nasdaq climbed 2.53% and the Dow was up 1.84% as stocks pushed higher after President Donald Trump said planned strikes on Iran were called off. “Our technical indicators are looking relatively oversold here,” Robert Phipps, director at Per Stirling Capital Management, told Reuters.